Entre las marcas de nuestros más de 25 colaboradores destaca TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina el 31 dic( quedan 8 días )
7-Methoxyisoflavone
CAS:7-Methoxyisoflavone is an activator of adenosine monophosphate-activated protein kinase (AMPK).Fórmula:C16H12O3Pureza:99.93% - 99.94%Forma y color:SolidPeso molecular:252.26GSK3-IN-2
CAS:<p>GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.</p>Fórmula:C17H19N3OSPureza:98.8%Forma y color:SolidPeso molecular:313.42MMV688845
CAS:MMV688845: NTM RNA polymerase inhibitor, kills Mycobacterium abscessus, and fights TB.Fórmula:C24H25N3O3SForma y color:SolidPeso molecular:435.54VU6019650
VU6019650: potent M5 mAChR antagonist, IC50=36nM. May help with OUD, crosses blood-brain barrier, affects VTA dopamine neurons.Fórmula:C18H22FN3O3S2Forma y color:SolidPeso molecular:411.51SERT-IN-2
SERT-IN-2, a potent SERT inhibitor (IC 50 = 0.58 nM), exhibits promising efficacy as an anti-depressant.Forma y color:SolidCamA-IN-1
CamA-IN-1, specific Clostridioides difficile methyltransferase inhibitor, IC50 = 0.4μM, Kd = 0.2μM, targets CDI research.Fórmula:C23H36N6O6Forma y color:SolidPeso molecular:492.57BTK-IN-22
CAS:BTK-IN-22 is a selective BTK inhibitor with IC50 of 0.9 nM; also targets BLX, BMX (IC50s: 1.4, 1.2 nM); better selectivity than Ibrutinib.Fórmula:C26H26N6O2Forma y color:SolidPeso molecular:454.52BTK-IN-23
CAS:BTK-IN-23: BTK inhibitor, IC50=12.8 nM; also blocks BLX (35.6 nM), BMX (5.7 nM); better selectivity than Ibrutinib.Fórmula:C27H28N6O2Forma y color:SolidPeso molecular:468.55FABP-IN-2
CAS:FABP-IN-2, a novel ligand for FABP3, demonstrates inhibition of both FABP3 and FABP4 with IC50 values of 1.16 μM and 4.27 μM, respectively.Fórmula:C25H21ClN2O3Forma y color:SolidPeso molecular:432.9MLKL-IN-5
CAS:MLKL-IN-5 is a potent MLKL inhibitor that mediates necroptosis .Fórmula:C18H20N6O4SForma y color:SolidPeso molecular:416.45HBV-IN-29
CAS:HBV-IN-29 (ex8), a flavone derivative, inhibits cccDNA in HBV research.Fórmula:C22H19ClO6Forma y color:SolidPeso molecular:414.84HBV-IN-30
CAS:<p>HBV-IN-30, a flavone derivative, inhibits cccDNA in HBV research.</p>Fórmula:C22H18BrClO6Forma y color:SolidPeso molecular:493.73HBV-IN-31
CAS:HBV-IN-31: strong cccDNA inhibitor, anti-HBV, IC50=0.13 µM HBsAg, hampers cell growth.Fórmula:C23H18ClNO6Forma y color:SolidPeso molecular:439.85HBV-IN-32
CAS:HBV-IN-32 is a strong cccDNA inhibitor with an IC50 of 0.14 µM against HBsAg, also halting cell growth.Fórmula:C22H19ClO5SForma y color:SolidPeso molecular:430.9Vonifimod
CAS:Vonifimod is an immunomodulator .Fórmula:C17H34N4O2Forma y color:SolidPeso molecular:326.48SRI-42127
CAS:SRI-42127 is a novel small molecule inhibitor of the RNA regulatory factor HuR that inhibits tumor growth and reduces neuropathic pain following nerve injury.Fórmula:C19H20N6OPureza:99.66%Forma y color:SolidPeso molecular:348.4DC-BPi-03
CAS:DC-BPi-03 is a potent BPTF-BRD inhibitor with an IC 50 of 698.3 nM and a K d of 2.81 μM .Fórmula:C14H14N4O2SPureza:98.96%Forma y color:SolidPeso molecular:302.35mHTT-IN-1
CAS:mHTT-IN-1 is a potent inhibitor of toxic mHTT, linked to Huntington's disease, with an EC50 of 46 nM.Fórmula:C18H19N7OSForma y color:SolidPeso molecular:381.45C-178
CAS:<p>C-178 inhibits STING by binding Cys91, blocking palmitoylation and TBK1 activation in HEK293T cells.</p>Fórmula:C17H10N2O5Pureza:97.69%Forma y color:SolidPeso molecular:322.27Fabimycin
CAS:Fabimycin, a FabI inhibitor, combats drug-resistant gram-negative bacterial infections effectively.Fórmula:C23H25ClN4O3Forma y color:SolidPeso molecular:440.92ZIKV-IN-3
CAS:ZIKV-IN-3, an andrographolide derivative, inhibits ZIKV NS5 MTase (IC50: 18.34 μM) and replication. Used for Zika virus research.Fórmula:C39H41NO4Forma y color:SolidPeso molecular:587.75WNK1-IN-1
CAS:WNK1-IN-1, a WNK1 inhibitor (IC50: 1.6 μM), also inhibits OSR1 phosphorylation (IC50: 4.3 μM), used in blood pressure and cancer research.Fórmula:C13H15BrCl2N2O4SPureza:98.09%Forma y color:SolidPeso molecular:446.14iBRD4-BD1
CAS:iBRD4-BD1 inhibits BRD4 bromodomain selectively with 12 nM IC50, useful in inflammation and cancer research.Fórmula:C29H30F3N5OForma y color:SolidPeso molecular:521.58TDI-11861
CAS:TDI-11861 is a second-gen sAC (ADCY10) inhibitor with an IC50 of 5.5 nM and slow dissociation.Fórmula:C22H25ClF2N6O3Forma y color:SolidPeso molecular:494.92MurA-IN-3
CAS:MurA-IN-3, a reversible pyrrolidinedione-based MurA inhibitor, exhibits an IC50 of 4.5 μM against MurA and demonstrates antibacterial activity [1].Fórmula:C27H23ClN2O5SForma y color:SolidPeso molecular:523APE1-IN-2
CAS:<p>APE1-IN-2 (AP1), a Pt(IV) proagent, targets APE1 protein, induces DNA damage, and triggers apoptosis with anticancer effects.</p>Fórmula:C9H12Cl2N4O5PtPureza:98%Forma y color:SolidPeso molecular:522.21Nucleozin
CAS:Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication.Fórmula:C21H19ClN4O4Pureza:97.72%Forma y color:SolidPeso molecular:426.85AXL-IN-13
CAS:AXL-IN-13: potent, oral AXL inhibitor, IC50=1.6nM, Kd=0.26nM, anti-cancer, inhibits EMT, cell migration & invasion.Fórmula:C34H41FN6O5Pureza:99.95%Forma y color:SolidPeso molecular:632.72ATR-IN-20
ATR-IN-20: potent ATR inhibitor, IC50=3nM; inhibits mTOR, IC50=18nM; selective vs PI3Kα, ATM, DNA-PK; good pharmacokinetics; anticancer.Fórmula:C29H31N5O4SForma y color:SolidPeso molecular:545.65FAAH-IN-7
<p>FAAH-IN-7: Reversible FAAH inhibitor, IC50=8.29 nM, reduces oxidative stress, neuroprotective in neuroinflammation.</p>Fórmula:C26H29N3O4Forma y color:SolidPeso molecular:447.53BTK-IN-17
BTK-IN-17: selective, oral BTK inhibitor, IC50=13.7 nM, reduces p-BTK Y223/p-PLCγ2 Y1217, anti-inflammatory.Fórmula:C26H23N7O2Forma y color:SolidPeso molecular:465.51ALR2-IN-2
ALR2-IN-2 inhibits ALR2 (27 nM IC50) & ALR1 (228 nM IC50), used in diabetes complication research.Fórmula:C17H11FN2O2S2Forma y color:SolidPeso molecular:358.41ALR2-IN-3
ALR2-IN-2 inhibits ALR2 strongly (IC50: 22 nM) and ALR1 less (IC50: 116 nM), used in diabetes complication studies.Fórmula:C17H12N2O3S2Forma y color:SolidPeso molecular:356.42TrkA-IN-3
TrkA-IN-3: potent allosteric TrkA inhibitor, IC50=22.4 nM, >8000x selective over TrkB/C, for pain research.Fórmula:C24H17F3N4O3Forma y color:SolidPeso molecular:466.41TrkA-IN-4
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a prodrug of TrkA-IN-3 . TrkA-IN-4 exhibits potent antinociceptive effects [1] .Fórmula:C27H21F3N4O5Forma y color:SolidPeso molecular:538.47Mps1-IN-5
CAS:Mps1-IN-5: oral Mps1 inhibitor with 29 nM IC50, induces apoptosis, G2/M arrest, and has anti-tumor properties.Fórmula:C24H25N9Forma y color:SolidPeso molecular:439.52RET-IN-20
RET-IN-20: potent RET inhibitor (IC50 = 13.7 nM), reduces p-Ret/p-Shc, induces apoptosis, anti-tumor effects.Fórmula:C32H33FN6O4Forma y color:SolidPeso molecular:584.64Ursocholic acid
CAS:Ursocholic acid, a bile acid found predominantly in bile of mammals.Fórmula:C24H40O5Pureza:98.89% - 99.62%Forma y color:SolidPeso molecular:408.57AXL-IN-14
CAS:AXL-IN-14: orally active, potent AXL inhibitor (IC50=0.8 nM); hinders Gas6/AXL migration, invasion; lowers p-AXL, p-AKT; anti-tumor.Fórmula:C32H24F2N4O4Pureza:98%Forma y color:SolidPeso molecular:566.55DENV-IN-7
CAS:DENV-IN-7, a flavone analog, inhibits dengue virus at 70 nM EC50 with low toxicity to normal cells.Fórmula:C24H22O8Forma y color:SolidPeso molecular:438.43DENV-IN-9
CAS:DENV-IN-9 is a DENV2 inhibitor with an EC 50 of 0.88 μM .Fórmula:C15H9BrO5Forma y color:SolidPeso molecular:349.13(R)-ZG197
(R)-ZG197: Activates Sa ClpP (EC50=1.5μM) & Hs ClpP (EC50=31.4μM); selective for Sa ClpP.Fórmula:C28H35F3N4O3Forma y color:SolidPeso molecular:532.6(S)-ZG197
(S)-ZG197 is a compound that acts as a highly selective activator of the Staphylococcus aureus Caseinolytic Protease P (Sa ClpP), demonstrating efficacy at aFórmula:C28H35F3N4O3Forma y color:SolidPeso molecular:532.6FGFR-IN-9
FGFR-IN-9: oral FGFR inhibitor, IC50: 17.1 nM (FGFR4 WT), 29.6 (FGFR3), 30.7 (V550L), 46.7 (FGFR2), 64.3 nM (FGFR1).Fórmula:C25H28N6O3SForma y color:SolidPeso molecular:492.59JZP-MA-13
JZP-MA-13: selective α/β-hydrolase domain 6 inhibitor, IC 50 392 nM, doesn't inhibit MAGL/ABHD12/FAAH, used in PET imaging.Fórmula:C14H15FN4O3SForma y color:SolidPeso molecular:338.36BTK-IN-18
CAS:<p>BTK-IN-18 is a potent, reversible inhibitor of Bruton's tyrosine kinase (BTK) with an inhibitory concentration (IC50) of 0.002 µM.</p>Fórmula:C20H22Cl2N6OForma y color:SolidPeso molecular:433.33BTK-IN-19
CAS:BTK-IN-19 is a reversible BTK inhibitor with an IC 50 of <0.001 μM .Fórmula:C21H22Cl2N6OForma y color:SolidPeso molecular:445.35(E)-2-Decenoic acid
CAS:(E)-2-Decenoic acid (trans-2-Decenoic acid) is an unsaturated fatty acid found in royal jelly produced from the mandibular gland secretions of honeybees.Fórmula:C10H18O2Pureza:98%Forma y color:SolidPeso molecular:170.25CLK1-IN-2
<p>CLK1-IN-2: Metabolically stable, Clk1-selective inhibitor; IC50=1.7nM; useful in tumor, Duchenne MD, HIV-1, influenza research.</p>Fórmula:C16H12Cl2N2O2SForma y color:SolidPeso molecular:367.25TBK1-IN-1
CAS:TBK1-IN-1 is a TANK-binding kinase 1 inhibitor with anticancer activity.TBK1-IN-1 inhibits the expression of TBK1 downstream target genes, cxcl10 and ifnβ.Fórmula:C27H37N7O2Pureza:99.81% - >99.99%Forma y color:SolidPeso molecular:491.63RdRP-IN-5
CAS:<p>RdRP-IN-5 (compound 20), a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), has potential application in influenza research [1].</p>Fórmula:C23H21N3O5Pureza:98%Forma y color:SolidPeso molecular:419.43PARL-IN-1
PARL-IN-1: Strong PARL blocker, IC50 28 nM, boosts PINK1/Parkin mitophagy.Fórmula:C40H58N6O7Forma y color:SolidPeso molecular:734.92MenA-IN-1
MenA IN-1 inhibits MTB's MenA enzyme; IC50=13µM, GIC50=8µM, helps fight tuberculosis spread.Fórmula:C29H36N2O2Forma y color:SolidPeso molecular:444.61CB2R-IN-3
CB2R-IN-3 selectively blocks CB2R with high affinity, enhances anti-inflammatory cytokines, and can be used with CB65.Fórmula:C27H42N2OForma y color:SolidPeso molecular:410.64Merigolix
CAS:Merigolix is a potent gonadotrophin releasing hormone (GnRH) antagonist .Fórmula:C36H35F7N4O6Forma y color:SolidPeso molecular:752.68DHFR-IN-5
CAS:<p>DHFR-IN-5: potent, oral DHFR inhibitor, Ki 0.54 nM against mutant P. falciparum, anti-malarial.</p>Fórmula:C18H24N4O4Forma y color:SolidPeso molecular:360.41P 218
CAS:P 218 is a novel DHFR inhibitor with antimalarial activity and antifolate effects and can be used to study Buruli ulcer.Fórmula:C18H25ClN4O4Pureza:98.83%Forma y color:SoildPeso molecular:396.87MMV676584
CAS:MMV676584 has anti-tuberculosis avtivity. MMV676584 is a novel drug candidate for eumycetoma .Fórmula:C12H8ClFN2OS2Forma y color:SolidPeso molecular:314.79Pyrvinium pamoate
CAS:Pyrvinium pamoate (Pyrvinium embonate) is an old anthelminthic medicine for the treatment of enterobiasis , which re-attracts attention as an anti-cancer drugFórmula:C26H28N3C23H14O6Pureza:99.76% - >99.99%Forma y color:SolidPeso molecular:575.71JAK-IN-24
CAS:JAK-IN-24: JAK inhibitor, IC50: 0.534 nM (4 μM ATP), 24 nM (1mM ATP), STAT5 phosphorylation IC50: 86.171 nM.Fórmula:C20H25N5O2Forma y color:SolidPeso molecular:367.44GSK3-IN-3
CAS:<p>GSK3-IN-3 is a mitochondrial autophagy (mitophagy) inducer and GSK-3 inhibitor (IC50: 3.01 μM) that induces parkin-dependent mitochondrial autophagy.</p>Fórmula:C24H35N3O4Pureza:99.37%Forma y color:SolidPeso molecular:429.55BI-685509
CAS:BI-685509: potent, oral sGC activator, boosts cGMP, enhances NO pathways, for CKD/DKD research.Fórmula:C34H38N4O5Forma y color:SolidPeso molecular:582.69OICR12694
CAS:<p>OICR12694 (JNJ-65234637) is an orally active inhibitor of B cell lymphoma 6 (BCL6) .</p>Fórmula:C29H28ClF3N8O4Forma y color:SolidPeso molecular:645.03Larotinib
CAS:Larotinib is an orally active, potent, and broad-spectrum tyrosine kinase inhibitor (TKI) with an IC50 of 0.6 nM for EGFR.Fórmula:C24H26ClFN4O4Pureza:99.73%Forma y color:SolidPeso molecular:488.94P2X7-IN-2
CAS:P2X7-IN-2 is a P2X7 receptor blocker, halts IL-Iβ release (IC50: 0.01 nM), researched for autoimmunity and heart issues.Fórmula:C22H21F4N3O2Forma y color:SolidPeso molecular:435.41Ketotifen
CAS:Ketotifen: Oral H1 blocker & mast cell stabilizer, inhibits 6-phosphogluconate dehydrogenase, antiviral, for EAE & asthma prevention research.Fórmula:C19H19NOSForma y color:SolidPeso molecular:309.43Articaine
CAS:<p>Articaine (Hoe-045 free base), an amide anesthetic featuring an ester group, effectively relieves pain by reversibly binding to the α-subunit of the voltage-</p>Fórmula:C13H20N2O3SForma y color:SolidPeso molecular:284.37Obtusalin
CAS:<p>Obtusalin, a triterpenoid initially identified in R. dauricum, exhibits UV absorption at 210 nm and possesses antibacterial properties.</p>Fórmula:C30H50O2Forma y color:SolidPeso molecular:442.72NP118809
CAS:<p>NP118809 (39-1B4) is a potent N-type calcium channel blocker(IC50 : 0.11 μM).</p>Fórmula:C32H32N2OPureza:97.74% - 98.68%Forma y color:SolidPeso molecular:460.61Quipazine
CAS:<p>Quipazine: 5-HT agonist, Ki 1.4 nM at 5-HT3R, anti-SARS-CoV-2 (EC50 31.64 μM), for neurological research.</p>Fórmula:C13H15N3Forma y color:SolidPeso molecular:213.28Prenderol
CAS:<p>Prenderol, a potent central-nervous-system (CNS) depressant, exhibits anticonvulsant activity.</p>Fórmula:C7H16O2Forma y color:SolidPeso molecular:132.2BAP1-IN-1
CAS:BAP1-IN-1 is an inhibitor of the catalytic activity of BRCA1-associated protein 1 (BAP1), which is related to cancer and can be used to study cancer.Fórmula:C18H16N2O2Pureza:98.11%Forma y color:SolidPeso molecular:292.33AP 24149
CAS:AP 24149, a potent dual inhibitor targeting Src and Abl, exhibits IC50 values of 9.1 nM for Src and 3.6 nM for Abl, respectively.Fórmula:C23H24N5OPForma y color:SolidPeso molecular:417.44SC 34301
CAS:SC 34301 (Enisoprost), a strong oral PGE1 analog, decreases bacterial translocation and increases burned mice survival.Fórmula:C22H36O5Forma y color:SolidPeso molecular:380.52BCX-1898
CAS:BCX-1898: Oral cyclopentane-based neuraminidase inhibitor for flu A/B; EC50 <0.01-21µM; effective in mouse models.Fórmula:C17H32N4O3Forma y color:SolidPeso molecular:340.46CCG-2046
CAS:CCG-2046 is a chemical inhibitor targeting RGS4, demonstrating an inhibition concentration (IC50) of 4.3 μM for the interaction between RGS4 and Gαo signal.Fórmula:C11H10N4Forma y color:SolidPeso molecular:198.22TTT 3002
CAS:TTT 3002: oral FLT3 inhibitor for AML research, blocks D835 mutations, potent at 0.2 nM IC50.Fórmula:C27H23N5O3Forma y color:SolidPeso molecular:465.502,3-Diaminopropionic acid
CAS:2,3-Diaminopropionic acid (L-2,3-Diaminopropionic acid) is an amino acid that is a precursor of antibiotics and staphyloferrin B a siderophore produced byFórmula:C3H8N2O2Pureza:99.61% - 99.90%Forma y color:SolidPeso molecular:104.11BAY-3827
CAS:BAY-3827 is an AMPK inhibitor with antiproliferative activity and antitumor activity. BAY-3827 inhibits the phosphorylation of acetyl CoA carboxylase 1.Fórmula:C27H25FN6OPureza:99.90%Forma y color:SolidPeso molecular:468.53CAY10581
CAS:CAY10581, a derivative of pyranonaphthoquinone, serves as a highly specific and reversible uncompetitive inhibitor of IDO, demonstrating potency with an IC50Fórmula:C22H21NO4Forma y color:SolidPeso molecular:363.41A-943931
CAS:A-943931 is a selective histamine H4 receptor antagonist with human and rat Ki values of 4.6 and 3.8 nM respectively.inhibits the scratching response in mice.Fórmula:C17H21N5Pureza:99.79%Forma y color:SolidPeso molecular:295.38NOS-IN-3
CAS:NOS-IN-3: potent, selective iNOS inhibitor; IC50 of 4.6 µM; spares eNOS; low toxicity; potential for septic shock treatment.Fórmula:C10H15N3OForma y color:SolidPeso molecular:193.25TPN729MA
CAS:<p>TPN729MA, a potent PDE5 inhibitor, IC50: 2.28 nM, targets erectile dysfunction research.</p>Fórmula:C29H40N6O8SForma y color:SolidPeso molecular:632.73Ac32Az19
CAS:Ac32Az19 is a potent, non-toxic, and highly selective inhibitor of Breast Cancer Resistance Protein (BCRP), demonstrating an EC50 of 13 nM in BCRP-overexpressedFórmula:C37H33N3O6Forma y color:SolidPeso molecular:615.67(-)SHIN2
<p>'(-)SHIN2 isomer of (+)SHIN2, an SHMT inhibitor with antileukemic properties; enhances Methotrexate's effect in vivo.</p>Fórmula:C23H26N4O3Forma y color:SolidPeso molecular:406.48NYX-2925
CAS:NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. Useful for CNS disorder studies.Fórmula:C14H23N3O4Forma y color:SolidPeso molecular:297.35ICA-121431
CAS:<p>ICA-121431: a potent Nav1.7 inhibitor (IC50=19 nM for rat), minimal effect on human Nav1.5/Nav1.7.</p>Fórmula:C23H19N3O3S2Pureza:98.06%Forma y color:SolidPeso molecular:449.55RP101442
CAS:RP101442: Ozanimod metabolite, selective S1PR1 agonist, EC50: 2.6 nM (S1PR1), 171 nM (S1PR5).Fórmula:C23H22N4O3Forma y color:SolidPeso molecular:402.45RP101988
RP101988, a potent Ozanimod metabolite, selectively targets S1PR1 with EC50 of 0.19 nM and S1PR5 at 32.8 nM.Fórmula:C23H22N4O4Forma y color:SolidPeso molecular:418.45C-di-IMP
CAS:Cyclic-di-IMP (C-di-IMP), a STING agonist, serves as a research tool in tumor studies.Fórmula:C20H22N8O14P2Forma y color:SolidPeso molecular:660.38MEK-IN-5
CAS:<p>MEK-IN-5: strong MEK inhibitor and NO donor, reduces pMEK/pERK dose/time-dependently, triggers apoptosis in MDA-MB-231 cells.</p>Fórmula:C29H27FN4O10S2Forma y color:SolidPeso molecular:674.67BLK-IN-2
CAS:<p>BLK-IN-2为一种高效、选择性且不可逆的B-淋巴酪氨酸激酶(BLK)抑制剂，具有5.9 nM的IC50值。该化合物亦能抑制BTK，其IC50值为202.0 nM。BLK-IN-2在多种淋巴瘤细胞中展现出显著的抗增殖作用。</p>Fórmula:C39H41N9O3Forma y color:SolidPeso molecular:683.8Zn(BQTC)
CAS:Zn(BQTC) inhibits mtDNA and nDNA, damages mitochondria/nuclei, triggers apoptosis, and targets A549R cancer cells.Fórmula:C30H36Cl2N5O3ZnPureza:98%Forma y color:SolidPeso molecular:650.92UniPR505
CAS:<p>UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.</p>Fórmula:C39H57N3O5Pureza:98.23%Forma y color:SolidPeso molecular:647.89UR-MB108
CAS:UR-MB108 is a potent and selective inhibitor of ABCG2 (BCRP), displaying an IC50 value of 79 nM, and exhibits stability in blood plasma.Fórmula:C40H38N6O4Forma y color:SolidPeso molecular:666.77Kinetin riboside
CAS:Kinetin riboside (N6-Furfuryladenosine) can induce apoptosis in cancer cells. It inhibits the proliferation of HCT-15 cells(IC50 of 2.5 μM)Fórmula:C15H17N5O5Pureza:98.17%Forma y color:White SolidPeso molecular:347.33RSV-IN-7
CAS:<p>RSV-IN-7 (example 253) is a RSV inhibitor ( EC 50 : < 0.4 μΜ) .</p>Fórmula:C27H22F3N7O3Forma y color:SolidPeso molecular:549.50BAY-3153
CAS:BAY-3153 is a selective CCR1 ( C-C motif chemokine receptor 1 ) antagonist (human IC 50 =3 nM ; rat IC 50 =11 nM ; mice IC 50 =81 nM) .Fórmula:C25H29Cl2N3O4Forma y color:SolidPeso molecular:506.42GNE-2256
CAS:GNE-2256, also known as molecule 19, is an orally active compound that inhibits Interleukin 1 receptor-associated kinase 4 (IRAK4) with a K i of 1.4 nM and hasFórmula:C24H27FN6O4Forma y color:SolidPeso molecular:482.51
